CYDY And SATC Update The Investment Community In All-New Interviews With WallSt.net

NEW YORK, Jan. 23 /PRNewswire/ -- On January 20, Allen D. Allen, CEO for CytoDyn, Inc. updated the investment community in an all-new, exclusive interview with www.wallst.net . Interview highlights include detailed discussions on the following topics:

- The Company's targeted immune therapy for AIDS - Preliminary clinical trial results - Advantages of an immune therapy over traditional drug "cocktails" - Current capitalization - Bios of key executives - Long-term growth prospects - Near-term strategic and financial milestones

On January 20, Millard Firebaugh, President and Chief Operating Officer for SatCon Technology Corp. updated the investment community in an all-new, exclusive interview with www.wallst.net . Interview highlights include detailed discussions on the following topics:

- the Company's diversification strategy - recent release of the Company's 500 kilowatt PowerGate inverter, and its advantages over other power management systems - alternative energy trends - the Company's target markets, and technology to serve them - upcoming strategic milestones

To hear the interviews in their entirety, visit www.wallst.net , and click on "Interviews/Podcasts." Interviews require free registration, and can be accessed either by locating the respective company's ticker symbol under the appropriate exchange on the left-hand column of the "Interviews/Podcasts" section of the site, or by entering the respective company's ticker symbol in the Search Archive window.

About WallSt.net

www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. . The website is a leading provider of financial news, media, tools and community-driven applications for investors. www.wallst.net offers visitors free membership to its in-depth executive interviews, exclusive editorial content, breaking news, and several proprietary applications. In addition to its website, WallStreet Direct organizes investor conferences, publishes a newspaper, and provides multimedia advertising solutions to small and mid-sized publicly traded companies. We are expecting to receive two thousand two hundred fifty dollars from CytoDyn, Inc. for the dissemination of this press release. For a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp

Contact:

Nick Iyer

1-800-4-WALL-ST

WallStreet Direct, Inc.

CONTACT: Nick Iyer of WallStreet Direct, Inc., +1-800-4-WALL-ST

Back to news